Name | Enobosarm |
---|---|
Synonyms |
GTx-024
(2S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide UNII-O3571H3R8N Ostarine MK-2866 Propanamide, 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methyl-, (2S)- MK-2286 |
Description | Ostarine(MK-2866; GTX-024) is a modulator of human androgen receptor.IC50 value:Target: androgen receptorOstarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 632.3±55.0 °C at 760 mmHg |
Molecular Formula | C19H14F3N3O3 |
Molecular Weight | 389.328 |
Flash Point | 336.2±31.5 °C |
Exact Mass | 389.098724 |
PSA | 106.14000 |
LogP | 4.83 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.578 |